日本手術機器人系統市場 - 2025 至 2033 年

日本手術機器人系統市場在 2024 年達到 5.3962 億美元，預計到 2033 年將達到 21.0776 億美元，在 2025-2033 年的預測期內複合年成長率為 16.5%。

手術機器人系統是一種複雜而先進的醫療技術，由機器人設備、軟體和儀器組成，旨在協助外科醫生以更高的精度、靈活性和控制力執行手術程序。這些系統利用機械手臂、手術器械、視覺化技術和先進的控制系統，幫助外科醫生以更有效、更少創傷的方式進行微創甚至傳統開放性手術。

日本手術機器人系統市場經歷了快速成長，這受到多種因素的推動，包括技術進步、對微創手術的需求不斷增加以及對改善手術結果的關注。日本不同醫療機構對這些手術機器人系統的需求正在不斷發展。例如，根據美國國立衛生研究院（NIH）統計，日本已有180多家機構安裝了達文西手術系統。手術機器人系統的日益普及正在加速日本市場的需求。

市場動態：

促進因素與約束因素

日本整形外科手術日益增多

日本外科手術的增加極大地推動了日本手術機器人系統市場的成長，預計將在預測期內推動市場的發展。日本人口老化迅速，65歲以上人口約佔總人口的三分之一，約3,623萬人，這一比例在主要經濟體中最高。隨著年齡的成長，人們通常需要接受複雜的手術來治療心血管疾病、癌症、骨科疾病和脊椎疾病等。

例如，根據Springer Nature發表的文章，日本2022年共進行了61,606例心血管手術，其中包括120例VAD植入手術和79例心臟移植手術。此外，根據美國國立衛生研究院的數據，日本一年內進行了約 130 萬例骨科住院手術。隨著人口老化的加劇，預計手術量將會增加，這可能會增加日本對手術機器人系統的需求，以獲得更好的手術效果。

由於人口老化，日本心血管疾病、癌症和糖尿病等慢性疾病的發生率不斷上升。這些情況通常需要進行大手術，這在技術上具有挑戰性並且對精度有很高的要求。慢性病負擔的持續加重推動了對機器人輔助手術的需求，尤其是在腫瘤科、心臟科和泌尿科等專業領域。外科醫生依靠機器人來執行這些複雜的手術，以獲得更好的結果和更少的併發症，從而推動機器人系統的採用。

例如，根據日本臨床腫瘤學會的數據，日本的癌症病例數一直在穩定增加，尤其是前列腺癌，它是發病的主要原因之一。根據東京國際大濠醫院介紹，目前日本共有300多台機器人手術單位投入運行，每年實施超過1.3萬例機器人輔助根治性攝護腺切除術。機器人輔助根治性攝護腺切除術、機器人輔助部分腎切除術等泌尿科機器人手術正快速普及。同樣，在預測期內，其他手術（如骨科、心臟病學等）對手術機器人系統的需求也預計會上升。

來自傳統手術系統的激烈競爭

傳統手術系統的激烈競爭是阻礙日本手術機器人系統市場成長的因素之一。雖然機器人手術系統在精準度、微創手術和改善患者治療效果方面具有顯著優勢，但由於成本、熟悉程度和初始投資較低等因素，傳統手術方法在日本的許多手術中仍然占主導地位。

日本廣泛採用機器人手術系統的主要障礙之一是初始成本高。達文西手術系統和美敦力 Hugo 系統等手術機器人系統的前期成本相當高，通常超過數百萬美元。這些系統還需要昂貴的維護、訓練和升級。

例如，單一達文西 Xi 手術系統的成本約為 100 萬至 250 萬美元，還不包括持續的維護和培訓費用。相比之下，傳統手術系統便宜得多，許多腹腔鏡設備系統的價格為 50,000 至 200,000 美元，這使得小型醫院和醫療機構更容易接受。

日本的外科醫生普遍精通傳統手術技術，尤其是在腹腔鏡手術、骨科和一般外科等領域。這些技術已經很成熟，醫療專業人員也樂於使用它們。在日本，腹腔鏡手術廣泛應用於胃腸道手術，外科醫生經驗豐富且技術嫻熟。

目錄

第1章：市場介紹和範圍

• 報告目標
• 報告範圍和定義
• 報告範圍

第 2 章：高階主管見解與關鍵要點

• 市場亮點和戰略要點
• 主要趨勢和未來預測
• 按類型分類的程式碼片段
• 按應用程式截取的程式碼片段
• 最終用戶的程式碼片段

第 3 章：動態

• 影響因素
  • 驅動程式
    • 日本整形外科手術日益增多
  • 限制
    • 來自傳統手術系統的激烈競爭
  • 機會
  • 影響分析

第4章：戰略洞察與產業展望

• 市場領導者和先驅者
  • 新興先鋒和傑出參與者
  • 擁有最大銷售品牌的成熟領導者
  • 擁有成熟產品的市場領導者
• CXO 觀點
• 最新進展與突破
• 案例研究/正在進行的研究
• 監管和報銷情況
• 波特五力分析
• 供應鏈分析
• SWOT 分析
• 未滿足的需求和差距
• 市場進入和擴張的推薦策略
• 情境分析：最佳情況、基本情況和最壞情況預測
• 定價分析和價格動態
• 關鍵意見領袖

第 5 章：手術機器人系統市場（按類型）

• 機器人輔助手術系統
• 手術機械手臂
• 自主手術機器人

第 6 章：手術機器人系統市場（按應用）

• 骨科手術
• 婦科手術
• 泌尿科
• 心臟手術
• 神經外科
• 一般外科
• 其他

第 7 章：手術機器人系統市場（以最終用戶分類）

• 醫院
• 門診手術中心
• 專科診所
• 其他

第 8 章：競爭格局與市場定位

• 競爭概況和主要市場參與者
• 市佔率分析與定位矩陣
• 策略夥伴關係、合併和收購
• 產品組合和創新的關鍵發展
• 公司基準化分析

第9章：公司簡介

• Medicaroid Corporation
• 公司概況
• 產品組合和描述
• 財務概覽
• 主要進展
• SWOT 分析
• Kawasaki Heavy Industries, Ltd.
• TELEXISTENCE Inc.
• Sony Group Corporation
• Intuitive Surgical
• Medtronic plc
• MicroPort Scientific Corporation
• Smith+Nephew
• ASAHI SURGICAL ROBOTICS CO., LTD.

第 10 章：假設與研究方法

• 資料收集方法
• 數據三角測量
• 預測技術
• 數據驗證和確認

第 11 章：附錄

The Japan surgical robot systems market reached US$ 539.62 million in 2024 and is expected to reach US$ 2,107.76 million by 2033, growing at a CAGR of 16.5% during the forecast period of 2025-2033.

A surgical robot system is a complex and advanced medical technology that consists of robotic devices, software, and instruments designed to assist surgeons in performing surgical procedures with greater precision, flexibility, and control. These systems use robotic arms, surgical instruments, visualization technologies, and advanced control systems to help surgeons conduct minimally invasive or even traditional open surgeries in a more effective and less invasive manner.

The Japan surgical robot systems Market has seen rapid growth driven by various factors, including advancements in technology, increasing demand for minimally invasive surgeries, and a focus on improving surgical outcomes. The demand for these surgical robot systems in Japan is evolving across different healthcare institutions. For instance, according to the National Institute of Health (NIH), more than 180 institutions have installed the da Vinci surgical system in Japan. This rising adoption of surgical robot systems is accelerating the market demand in Japan.

Market Dynamics: Drivers & Restraints

Rising surgical procedures in Japan

The rising surgical procedures in Japan is significantly driving the growth of the Japan surgical robot systems market and is expected to drive the market over the forecast period. Japan has a rapidly aging population, with almost a third of its population over 65, an estimated 36.23 million, the highest percentage among major economies. As people age, they often require complex surgeries for conditions like cardiovascular diseases, cancer, orthopedic issues, and spinal disorders.

For instance, according to the article published by Springer Nature, a total of 61,606 cardiovascular surgeries, including 120 VAD implantations and 79 heart transplants, were performed in 2022 in Japan. Additionally, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. As the aging population rises, the surgical procedure volume is expected to rise, which may create a demand for surgical robot systems in Japan for better outcomes.

Chronic diseases, such as cardiovascular conditions, cancer, and diabetes, are on the rise in Japan, primarily due to the aging population. These conditions often require major surgeries that can be technically challenging and require high precision. The rising burden of chronic diseases is propelling the demand for robot-assisted surgeries, especially in specialties like oncology, cardiology, and urology. Surgeons rely on robots to perform these complex procedures with better outcomes and fewer complications, driving the adoption of robotic systems.

For instance, according to the Japanese Society of Clinical Oncology, the number of cancer cases in Japan has been steadily increasing, particularly prostate cancer, which is one of the leading causes of morbidity. According to the Tokyo International Ohori Hospital, currently, more than 300 robot surgery units are in operation in Japan, and there have been performed more than 13,000 cases per year of robot-assisted radical prostatectomy. Urological robot surgery, such as robot-assisted radical prostatectomy and robot-assisted partial nephrectomy, is rapidly becoming widespread in Japan. Similarly, the demand for surgical robot systems in other surgeries like orthopedics, cardiology, etc, is expected to rise in the forecast period.

High competition from traditional surgical systems

The high competition from traditional surgical systems is one of the factors hampering the growth of the Japan surgical robot systems market. While robotic surgical systems offer significant advantages in precision, minimally invasive procedures, and improved patient outcomes, traditional surgical methods still dominate many procedures in Japan due to factors like cost, established familiarity, and lower initial investment.

One of the primary barriers to the widespread adoption of robotic surgery systems in Japan is the high initial cost. Surgical robot systems like the da Vinci Surgical System and the Medtronic Hugo System come with significant upfront costs, often exceeding several million dollars. These systems also require costly maintenance, training, and upgrades.

For instance, a single da Vinci Xi Surgical System costs approximately $1 to $2.5 million, not including ongoing maintenance and training costs. In comparison, traditional surgical systems are significantly cheaper, with many laparoscopic equipment systems costing $50,000 to $200,000, making them more accessible for smaller hospitals and healthcare facilities.

Surgeons in Japan are generally highly skilled with traditional surgical techniques, especially in fields like laparoscopic surgery, orthopedics, and general surgery. These techniques are well-established, and medical professionals are comfortable using them. In the field of laparoscopic surgery, which is widely used in Japan for gastrointestinal procedures, surgeons are highly experienced and proficient.

Segment Analysis

The Japan surgical robot systems market is segmented based on type, application, and end-user.

Application:

Orthopedic surgery dominates in the application segment of Japan's surgical robot systems, with the highest market share.

Japan has one of the oldest populations in the world, with almost a third of its population over 65, an estimated 36.23 million, according to the World Economic Forum. As people age, they are more prone to degenerative joint diseases, including osteoarthritis, spinal disorders, and hip and knee joint diseases, all of which require orthopedic surgery.

For instance, according to the National Institute of Health, approximately 1.3 million orthopedic inpatient surgeries were performed in a year in Japan. The demand for joint replacements (especially knee and hip replacements) is rising sharply due to the aging population. As a result, orthopedic surgeries are a major driver for robotic systems, which enhance the precision of joint replacements, reduce recovery times, and improve patient outcomes.

Robotic systems, such as the MAKO Robotic-Arm Assisted Surgery (by Stryker) and RAS (Robot-Assisted Surgery) for knee and hip replacements, are playing a crucial role in transforming orthopedic procedures. These systems offer higher precision during surgeries, better alignment of prosthetics, and improved patient outcomes, which are especially important in joint replacement surgeries.

For instance, the MAKO Robotic-Arm Assisted Surgery system has been increasingly adopted in Japan for knee and hip replacement surgeries. This system allows surgeons to customize procedures based on 3D imaging and offers a greater range of motion and more accurate alignment, resulting in fewer complications and faster recovery times for patients.

Competitive Landscape

The major players in the Japan surgical robot systems market include Medicaroid Corporation, Kawasaki Heavy Industries, Ltd., TELEXISTENCE Inc., Sony Group Corporation, Intuitive Surgical, Medtronic plc, MicroPort Scientific Corporation, Smith+Nephew, ASAHI SURGICAL ROBOTICS CO., LTD., and others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan surgical robot systems market report delivers a detailed analysis with 36 key tables, more than 30 visually impactful figures, and 158 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Type
• 2.4. Snippet by Application
• 2.5. Snippet by End-User

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising surgical procedures in Japan
  • 3.1.2. Restraints
    • 3.1.2.1. High competition from traditional surgical systems
  • 3.1.3. Opportunity
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. Regulatory and Reimbursement Landscape
• 4.6. Porter's Five Forces Analysis
• 4.7. Supply Chain Analysis
• 4.8. SWOT Analysis
• 4.9. Unmet Needs and Gaps
• 4.10. Recommended Strategies for Market Entry and Expansion
• 4.11. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.12. Pricing Analysis and Price Dynamics
• 4.13. Key Opinion Leaders

5. Surgical Robot Systems Market, By Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  • 5.1.2. Market Attractiveness Index, By Type
• 5.2. Robotic-Assisted Surgical Systems*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 5.3. Surgical Robotic Arms
• 5.4. Autonomous Surgical Robots

6. Surgical Robot Systems Market, By Application

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 6.1.2. Market Attractiveness Index, By Application
• 6.2. Orthopedic Surgery*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Gynecology Surgery
• 6.4. Urological Surgery
• 6.5. Cardiac Surgery
• 6.6. Neurosurgery
• 6.7. General Surgery
• 6.8. Others

7. Surgical Robot Systems Market, By End-User

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  • 7.1.2. Market Attractiveness Index, By End-User
• 7.2. Hospitals*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Ambulatory Surgical Centers
• 7.4. Specialty Clinics
• 7.5. Others

8. Competitive Landscape and Market Positioning

• 8.1. Competitive Overview and Key Market Players
• 8.2. Market Share Analysis and Positioning Matrix
• 8.3. Strategic Partnerships, Mergers, & Acquisitions
• 8.4. Key Developments in Product Portfolios and Innovations
• 8.5. Company Benchmarking

9. Company Profiles

• 9.1. Medicaroid Corporation*
  • 9.1.1. Company Overview
  • 9.1.2. Product Portfolio and Description
  • 9.1.3. Financial Overview
  • 9.1.4. Key Developments
  • 9.1.5. SWOT Analysis
• 9.2. Kawasaki Heavy Industries, Ltd.
• 9.3. TELEXISTENCE Inc.
• 9.4. Sony Group Corporation
• 9.5. Intuitive Surgical
• 9.6. Medtronic plc
• 9.7. MicroPort Scientific Corporation
• 9.8. Smith+Nephew
• 9.9. ASAHI SURGICAL ROBOTICS CO., LTD.

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

• 10.1. Data Collection Methods
• 10.2. Data Triangulation
• 10.3. Forecasting Techniques
• 10.4. Data Verification and Validation

11. Appendix

• 11.1. About Us and Services
• 11.2. Contact Us